First peanut allergy therapy gets backing from U.S. regulators' expert advisers
September 13, 2019 at 16:47 PM EDT
A U.S. Food and Drug Administration advisory panel on Friday recommended approving the first therapy for peanut allergies, which affect over 1.6 million children in the United States, despite raising concerns about the risk of severe allergic reactions it poses to young patients.